Published in JAMA on July 12, 1985
Joint and limb symptoms in children after immunisation with measles, mumps, and rubella vaccine. BMJ (1992) 1.24
Can immunisation trigger rheumatoid arthritis? Ann Rheum Dis (1993) 0.84
Rubella in the United States: toward a strategy for disease control and elimination. Epidemiol Infect (1991) 0.80
Accuracy of single radial hemolysis test for rubella immunity when internal reference standards are used to estimate antibody levels. J Clin Microbiol (1987) 0.76
Joint California Department of Health Services-California Medical Association campaign to eliminate congenital rubella syndrome. West J Med (1988) 0.75
Rubella screening and immunization: its history and future-an ongoing challenge. Can Fam Physician (1987) 0.75
Measles antibody: reevaluation of protective titers. J Infect Dis (1990) 3.77
Rational strategy for rubella vaccination. Lancet (1983) 3.61
Patterns of transmission in measles outbreaks in the United States, 1985-1986. N Engl J Med (1989) 2.41
A persistent outbreak of measles despite appropriate prevention and control measures. Am J Epidemiol (1987) 2.13
Congenital rubella syndrome in the United States, 1970-1985. On the verge of elimination. Am J Epidemiol (1989) 2.12
From the Center for Disease control: current status of measles in the United States, 1973--1977. J Infect Dis (1978) 1.91
Appropriate age for measles vaccination in the United States. Dev Biol Stand (1986) 1.80
Age-specific risks of varicella complications. Pediatrics (1981) 1.76
Current status of mumps and mumps vaccine in the United States. Pediatrics (1978) 1.71
Duration of live measles vaccine-induced immunity. Pediatr Infect Dis J (1990) 1.70
Epidemiology of pertussis, Atlanta, 1977. J Pediatr (1981) 1.62
Measles outbreak among unvaccinated preschool-aged children: opportunities missed by health care providers to administer measles vaccine. Pediatrics (1989) 1.57
Rubella vaccination in the United States: a ten-year review. Epidemiol Rev (1980) 1.53
Fetal risk associated with rubella vaccine: an update. Rev Infect Dis (1985) 1.50
Varicella: complications and costs. Pediatrics (1986) 1.41
Varicella: clinical manifestations, epidemiology and health impact in children. Pediatr Infect Dis (1985) 1.39
Varicella vaccine trials in healthy children. A summary of comparative and follow-up studies. Am J Dis Child (1984) 1.26
Assessment of susceptibility to measles and rubella. JAMA (1982) 1.26
Universal immunization to interrupt rubella. Rev Infect Dis (1985) 1.25
Evaluation of varicella-zoster immune globulin: protection of immunosuppressed children after household exposure to varicella. J Infect Dis (1983) 1.24
A benefit-cost analysis of a childhood varicella vaccination programme. Postgrad Med J (1985) 1.24
The opportunity and obligation to eliminate rubella from the United States. JAMA (1984) 1.20
Measles among the Amish: a comparative study of measles severity in primary and secondary cases in households. J Infect Dis (1991) 1.20
A school-based measles outbreak: the effect of a selective revaccination policy and risk factors for vaccine failure. Am J Epidemiol (1990) 1.14
Deaths from varicella in infants. Pediatr Infect Dis (1985) 1.14
Preventing rubella: assessing missed opportunities for immunization. Am J Public Health (1987) 1.11
Measles and measles vaccine efficacy in a remote island population. Bull World Health Organ (1982) 1.10
Methods of assessing the impact of congenital rubella infection. Rev Infect Dis (1985) 1.10
A benefit-cost analysis of mumps vaccine. Am J Dis Child (1982) 1.08
Mumps in the workplace. Further evidence of the changing epidemiology of a childhood vaccine-preventable disease. JAMA (1988) 1.07
Immunizations in college health: the remaining tasks. J Am Coll Health (1987) 1.06
Fatal measles pneumonia without rash in a child with AIDS. J Infect Dis (1988) 1.04
Chickenpox in the United States, 1972--1977. J Infect Dis (1979) 1.03
Prevention of rubella transmission in medical facilities. JAMA (1982) 1.03
A measles outbreak at a college with a prematriculation immunization requirement. Am J Public Health (1991) 0.98
Perspectives on the relative resurgence of mumps in the United States. Am J Dis Child (1988) 0.96
Clostridium perfringens meningitis in an infant: case report and literature review. Pediatr Infect Dis J (1987) 0.94
Changing epidemiology of mumps and its impact on university campuses. Pediatrics (1989) 0.93
Elimination of rubella and congenital rubella from the United States. Pediatr Infect Dis (1985) 0.92
The effect of a school entry law on mumps activity in a school district. JAMA (1987) 0.91
Fetal risk associated with rubella vaccine. JAMA (1981) 0.91
Transmission of measles in medical settings. 1980 through 1984. JAMA (1986) 0.89
Measles vaccination in young adults. Ann Intern Med (1980) 0.85
Susceptibility of vaccine strains of varicella-zoster virus to antiviral compounds. Antimicrob Agents Chemother (1984) 0.83
Vaccines of importance in the hospital setting. Problems and developments. Infect Dis Clin North Am (1989) 0.81
Progress in Haemophilus type b polysaccharide vaccine use in the United States. Pediatrics (1988) 0.80
Vaccine-preventable diseases on college campuses: the emergence of mumps. J Am Coll Health (1989) 0.79
Vancomycin dosage in pediatrics reconsidered. Am J Dis Child (1984) 0.79
Resistance of seropositive volunteers to subcutaneous challenge with low-passage human cytomegalovirus. J Infect Dis (1985) 0.78
Rubella vaccination of hospital employees. JAMA (1981) 0.78
Assessing risks of rubella infection during pregnancy. A standardized approach. JAMA (1981) 0.78
Evidence against increasing rubella seronegativity among adolescent girls. Am J Public Health (1990) 0.77
Bactericidal activities of chloramphenicol and eleven other antibiotics against Salmonella spp. Antimicrob Agents Chemother (1984) 0.77
International measles importations United States, 1980-1985. Int J Epidemiol (1988) 0.76
International travel and the child younger than two years: II. Recommendations for prevention of travelers' diarrhea and malaria chemoprophylaxis. Pediatr Infect Dis J (1989) 0.76
Measles and vaccine protection. Br Med J (1979) 0.75
Measles hospitalizations, United States, 1977-84: comparison with national surveillance data. Am J Public Health (1987) 0.75
Testalgia associated with rubella infection. South Med J (1980) 0.75
Rubella vaccination and pregnancy. Br Med J (1978) 0.75
An evaluation of the United States rubella immunization program. Am Ann Deaf (1980) 0.75
Measles vaccine in egg-allergic children. Pediatrics (1980) 0.75
Postpartum rubella immunization. J Infect Dis (1986) 0.75
Epidemic potential of measles and rubella. J Am Coll Health Assoc (1980) 0.75
Rubella hemaggluttination inhibition titers. JAMA (1982) 0.75
Measles vaccine urged for male employees. Hosp Infect Control (1979) 0.75
Rubella and congenital rubella surveillance, 1983. MMWR CDC Surveill Summ (1984) 0.75
Haemophilus influenzae b polysaccharide vaccine. Physician acceptance and use of a new vaccine. Am J Dis Child (1986) 0.75
Cost-benefit analysis of rubella screening. N Engl J Med (1979) 0.75
Prevention of rubella in hospitals. Am J Infect Control (1983) 0.75
A cost-effectiveness analysis of measles outbreak control strategies. Am J Epidemiol (1987) 0.75
Intravenous cholangiography in the rhesus monkey. part I: Determination of optimal iodipamide dose during a one-hour infusion. Invest Radiol (1976) 0.75
Rubella: the U. S. experience. Dev Biol Stand (1979) 0.75
Update: immunizations during pregnancy. J Med Soc N J (1984) 0.75
A profile of mothers giving birth to infants with congenital rubella syndrome. An assessment of risk factors. Am J Dis Child (1990) 0.75
Measles vaccine and the course of subacute sclerosing panencephalitis. Lancet (1978) 0.75
From the Center for Disease Control. Current status of rubella in the United States, 1969-1979. J Infect Dis (1980) 0.75
Varicella in the immunocompromised host. JAMA (1978) 0.75
Rubella: current status, diagnosis, outbreak control, and use of rubella vaccine in females of childbearing age. J Am Coll Health (1984) 0.75
Fetal risk associated with rubella vaccine: implications for vaccination of susceptible women. Obstet Gynecol (1985) 0.75
Rubella vaccination. Am J Dis Child (1979) 0.75